Peslie is pursuing a PhD in Health Economics which focuses on quantifying the economic impact of psoriasis as part of the Global Psoriasis Atlas. Understanding the economic burden of this disease entails understanding and valuing productivity loss, incremental healthcare costs, health related quality of life and well-being. This involves taking a more pragmatic societal perspective in valuing health and ultimately the value of current and future treatment investments. Impact of psoriasis on productivity will be explored and several methods used to value it in terms of presenteeism, absenteeism and unemployment
Prior to his PhD research, he worked on the economic evaluation of a National Institute of Health Research (NIHR) for Patient Benefit funded study that was evaluating a one-stop eye clinic for people who referred from opticians with lesions (Choroidal Nevomelanocytic Lessions), generally benign, at the back of the eye. He also worked on a number of studies as part of the Manchester Molecular Pathology Innovation Center (MMPATHIC http://www.biomarkers.manchester.ac.uk/about/mmpathic/) such as the economic evaluation of the Ultra-sensitive Cardiac Troponin I (cTnI) for risk stratification, Rule-out, and therapy guidance
Peslie holds a Master of Science in International Pharmacoeconomics and Health Economics from Cardiff University, UK and Bachelor of Pharmacy from The University of Zambia, Zambia. Over the years, he has worked as a Pharmacist and Health Economist. His experience spans the hospital, pharmaceutical and medical device industry on international projects in Health Economic Evaluation, Market Access, and Reimbursement for healthcare products. He is currently part of the Precision Medicine Economics Team (PMET) of the Manchester Centre for Health Economics. PMET is focused on the Economics of Precision medicine within healthcare.
He holds an external Lecturer position at Fresenius University of Applied Science in Germany where he teaches Economic evaluation and Decision Analytic Modelling to Masters students.
Peslie is curently reading for a PhD in Health Economics within the University of Manchester and a lecturer at Fresenius University of Applied Science in Germany. Peslie qualified as a Health Economist after his study for a Master of Science in International Pharmacoeconomics and Health Economics offered by Cardiff University in the United Kingdom and delivered at Fresenius University of Applied Science in Germany. In 2015, he was awarded the STIBET scholarship of the German Academic Exchange Service (DAAD), a scholarship for foreign students who exhibit outstanding performance in their studies at Germany Universities. Prior to joining the Manchester Centre for Health Economics in 2017, he worked in the Medical device Industry in Germany on Health Economic Evaluation and Market Access projects. Peslie graduated with a Bachelor of Pharmacy degree from the University of Zambia in 2011, after which he worked as a pharmacist in different settings before embarking on postgraduate studies